Trump Administration Secures Deal with Merck for Lower IVF Drug Costs and Tariff Relief

Deal Overview

• 🤝 President Donald Trump announced a significant agreement with German drug maker Merck (EMD Serono) aimed at reducing the cost of IVF drugs for US patients.
• 💡 In exchange for protection from future US tariffs, Merck will lower the cost of certain IVF drugs and price all new drugs in the US at the same level as other developed countries.

Cost Reductions and Access

• 💰 Merck's US arm, EMD Serono, will slash the cost of three key IVF drugs by up to 84% when used together.
• 📈 These discounted drugs will be sold directly to consumers via a new website, Trump RX, starting early next year.
• 🎯 The White House estimates this deal could save families approximately $2,200 per IVF cycle, with typical costs ranging from $12,000 to $25,000.

Manufacturing and Drug Development

• 🇺🇸 Merck has committed to shifting more of its drug production to the US, aligning with the administration's "bring manufacturing home" initiative.
• 🚀 The company will also fast-track approval for a new IVF drug, Pergois, using a special FDA program that significantly reduces review times.

Broader Healthcare Initiatives

• 🏥 The administration is expanding access to fertility care through insurance, allowing companies to offer standalone fertility coverage as an employee benefit.
• 💸 This new benefit option can be offered by employers immediately, similar to dental or vision insurance, though it is not mandated and has no government subsidies.
• 🤝 Merck joins other pharmaceutical companies like Pfizer and AstraZeneca in offering discounts for lower-income Americans through Medicaid in exchange for tariff relief.